SHARMEH Current Share Price | SHARMEH Stock Screener
SHARMEH
Healthcare Service Provider
SHARMEH Current Stock Price Today
Live Share Price BSE
₹89.70
▼
-2.30 (-2.50%)
As of September 18, 2026, the live SHARMEH share price (BSE: SHARMEH) is ₹89.70, down 2.50% from the previous close, with shares trading between ₹89.66 and ₹95.50 in today's trading session, and a 52-week range of ₹87.01–₹176.55.
Browse SHARMEH income statement to support your investment research.
Use the SHARMEH stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
SHARMEH Market Cap
₹30.22 Cr.
SHARMEH P/E Ratio (TTM)
25.05
SHARMEH P/B Ratio
2.31
EPS (TTM)
₹3.78
Dividend Yield
-
Debt to Equity
0.31
SHARMEH 52 Week High
₹176.55
SHARMEH 52 Week Low
₹87.01
Operating Margin
10.00%
Profit Margin
2.70%
SHARMEH Revenue (TTM)
₹37.00
EBITDA
₹4.00
Net Income
₹1.00
Total Assets
₹33.00
Total Equity
₹14.00
SHARMEH Current Share Price Chart
Track the current SHARMEH share price and stock price with an interactive chart. Analyse SHARMEH price trends, trading volume, historical performance, and volatility across different timeframes — the complete SHARMEH stock quote in one place.
SHARMEH Company Profile - Fundamental Screener
Screen SHARMEH company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SHARMEH shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE465H01012
SHARMEH Balance Sheet Screener
Screen SHARMEH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 33 | 28 | 25 | 24 | 19 | 19 | 20 | 22 | 16 | 18 |
| Current Assets | 20 | 15 | 7 | 12 | 10 | 11 | 12 | 15 | 8 | 9 |
| Fixed Assets | 8 | 9 | 8 | 9 | 7 | 6 | 4 | 5 | 6 | 6 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 14 | 13 | 11 | 11 | 10 | 9 | 8 | 8 | 8 | 8 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 10 | 8 | 7 | 6 | 5 | 5 | 4 | 4 | 4 | 3 |
SHARMEH Income Statement Screener - Profit & Revenue Analysis
Screen SHARMEH income statement and profit fundamentals.
Analyze SHARMEH quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for SHARMEH share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 37 | 36 | 30 | 24 | 21 | 17 | 11 | 16 | 16 | 16 | 17 | 17 | 17 |
| Expenses | 34 | 32 | 26 | 20 | 17 | 15 | 9 | 14 | 14 | 15 | 16 | 16 | 15 |
| EBITDA | 4 | 4 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| Operating Profit % | 10.00% | 10.00% | 12.00% | -10.00% | 16.00% | 13.00% | -8.00% | 12.00% | 4.00% | 9.00% | 10.00% | 5.00% | 8.00% |
| Depreciation | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| EPS | 3.60 | 3.78 | 3.79 | 2.02 | 2.96 | 2.07 | 1.94 | 1.18 | 0.81 | 0.40 | 0.26 | 0.09 | 1.74 |
SHARMEH Cash Flow Screener - Liquidity Fundamentals
Screen SHARMEH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 7 | -1 | 1 | 2 | 1 | 1 | -1 | 3 | 1 | 0 |
| Investing Activities | -3 | 5 | -4 | -2 | 3 | -2 | 2 | 0 | -1 | 0 |
| Financing Activities | -4 | -4 | 3 | -2 | -2 | -5 | 5 | -3 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | -2 | 2 | -5 | 5 | 0 | 0 | 0 |
SHARMEH Shareholding Pattern Screener
See SHARMEH shareholding pattern with promoter, FII, and DII holdings.
Check SHARMEH promoter holding and ownership changes for SHARMEH on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% | 53.63% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 33.33% | 33.33% | 33.50% | 33.50% | 33.49% | 33.31% | 32.83% | 32.83% |
| Other Holding | 13.03% | 13.03% | 12.86% | 12.86% | 12.88% | 13.06% | 13.53% | 13.53% |
| Shareholder Count | 4,210 | 4,211 | 4,068 | 4,147 | 4,377 | 4,226 | 3,698 | 3,697 |
SHARMEH Share Dividend Screener - Share Yield Analysis
Check SHARMEH dividend history with payout and yield data.
View SHARMEH dividend details including ex-dates and amounts for SHARMEH stock.
SHARMEH Stock Index Membership
See which indices include SHARMEH stock.
Check SHARMEH index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
SHARMEH Market Events Screener - Corporate Actions
Get SHARMEH corporate actions including splits, bonuses, and buybacks.
Check SHARMEH stock events that may affect SHARMEH share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-30 | 2026-09-30 | Annual General Meeting | NA | -1.91% |
| 2026-08-12 | 2026-08-12 | Quarterly Result Announcement | NA | -3.65% |
| 2026-05-30 | 2026-05-30 | Quarterly Result Announcement | NA | 7.74% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 15.01% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -3.69% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | -19.83% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -4.46% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | -1.35% |
| 2025-01-10 | 2025-01-10 | Quarterly Result Announcement | NA | 10.38% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -5.86% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | -16.46% |
SHARMEH Competitors Screener - Peer Comparison
Screen SHARMEH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 32,002 | 58.88 | 2,864 | 12.11% | 510 | 53.50 |
| Vijaya Diagnostic Centre | 15,455 | 82.34 | 835 | 19.34% | 173 | 58.30 |
| Metropolis Healthcare | 12,139 | 61.01 | 1,671 | 24.15% | 191 | 54.18 |
| Thyrocare Technologies | 8,749 | 50.45 | 846 | 20.48% | 163 | 38.82 |
| Nephrocare Health Services | 7,680 | 88.34 | 1,023 | 32.93% | 77 | 68.67 |
| Krsnaa Diagnostics | 1,784 | 18.74 | 773 | 4.05% | 106 | 47.23 |
| Suraksha Diagnostic | 1,686 | 48.71 | 314 | 22.55% | 31 | 55.15 |
| 3B BlackBio DX | 1,219 | 22.06 | 142 | 27.17% | 61 | 56.62 |
| One Global Service Provider | 1,056 | 14.36 | 498 | 237.06% | 69 | 45.33 |
| Health X Platform | 980 | -37.45 | 1,319 | 12.68% | -3 | 55.59 |
SHARMEH Company Announcements - News Screener
Screen SHARMEH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-15 | Reg. 34 (1) Annual Report. | - |
| 2026-09-15 | Notice Of 37Th Annual General Meeting Schedule To Be Held On 30Th September 2026 | - |
| 2026-09-15 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Tuesday September 08 2026 | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-12 | Approval Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of Listing Obligation And Disclosure Requirement 2015 | - |
| 2026-08-12 | Board Meeting Outcome for Approval Of Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of Listing Obligation And Disclosure Requirement 2015 | - |
| 2026-08-04 | Board Meeting Intimation for Approval Of IND-AS Compliant Standalone Un-Audited Financial Results For The Quarter Ended On 30Th June 2026 Pursuant To Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-07-09 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-22 | Closure of Trading Window | - |
| 2026-06-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-31 | Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2026 | - |
| 2026-05-30 | Board Meeting Outcome for Outcome Of Board Meeting Held On May 30 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations. 2015. | - |
| 2026-05-15 | Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2026. | - |
| 2026-04-29 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-11 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-03-27 | Closure of Trading Window | - |
| 2026-02-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-14 | Approval Of Unaudited Financial Results For The Quarter Ended December 31 2025 | - |
| 2026-02-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On February 14 2026 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | - |
| 2026-02-05 | Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 31St December 2025 | - |